Urinary proteomics and drug discovery in chronic kidney disease: a new perspective (original) (raw)

The research discusses the role of urinary proteomics in chronic kidney disease (CKD) and its potential in drug discovery. It highlights the pressing need for specific biomarkers to enhance diagnosis and treatment of CKD, given the increasing prevalence of the disease. The paper argues for the utilization of urine as a resource for biomarker identification due to its non-invasive nature and the complexity of proteins it contains. Recent advancements in proteomic technologies are noted as pivotal for clinical applications that could lead to better understanding, treatment, and possibly prevention of CKD progression.